S2Medical AB Capital Reinvestment Ratio
S2Medical AB capital reinvestment ratio. S2Medical AB (S2M) has a Capital Reinvestment Ratio of 3.03x as of June 2026, meaning it reinvests 3% of its operating cash flow (Skr169.00K) in capital expenditures (Skr512.00K). See S2M FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of S2Medical AB (2024–2025)
Capital reinvestment ratio of S2Medical AB from 2024 to 2025. This chart tracks S2Medical AB's Capital Reinvestment Ratio across 2 annual periods. See financial flexibility index of S2Medical AB to measure the company's free cash flow as a share of total liabilities.
S2Medical AB Capital Reinvestment Ratio by Year (2024–2025)
S2Medical AB capital reinvestment ratio by year from 2024 to 2025. For the full cash flow conversion analysis, see S2Medical AB operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | ▲ +693.5% |
| 2024 | 0.13x | Skr5.03 Million | Skr634.00K | — |